+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ONESOURCE

OneSource Specialty Pharma Share Price

 

 

OneSource Specialty Pharma live price: ₹1715.4. It opened at ₹1,725 vs previous close ₹1,738; intraday high/low: ₹1,734/₹1,703. The 50 & 200 DMA stand at ₹1,705.87/₹1,636.95.

OneSource Specialty Pharma Performance

  • Today's Low
  • ₹1,703
  • Today's High
  • ₹1,734
  • 52 Week Low
  • ₹1,057
  • 52 Week High
  • ₹2,248
  • Open Price₹1,725
  • Previous Close₹1,738
  • Volume143,763
  • 50 DMA₹1,705.87
  • 100 DMA₹1,644.47
  • 200 DMA₹1,636.95

OneSource Specialty Pharma Chart

Investment Returns

  • Over 1 Month -6.53%
  • Over 3 Month + 15.87%
  • Over 6 Month + 2.93%
  • Over 1 Year -11.32%

Smart Investing Starts Here Start SIP with OneSource Specialty Pharma for Steady Growth!

Invest Now

OneSource Specialty Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -266.5
  • PEG Ratio
  • 0.9
  • Market Cap Cr
  • 19,666
  • P/B Ratio
  • 3.4
  • Average True Range
  • 73.1
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 39.14
  • RSI
  • 42.33
  • MFI
  • 45.63

Latest Stock News Updates

OneSource Specialty Pharma Results Earnings Call for Q4FY26 & Full Year

Conference Call with OneSource Specialty Pharma Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

Onesource Specialty Pharma up 5% in weak market; rallies 21% in one week

The company will continue to derive strength from the existence of experienced promoters and positive outlook for the GLP1 segment, which is expected to yield revenue to the company from FY27 onwards.

Onesource Specialty Pharma tanks 18% on weak Q3; what should investors do?

In Q3, the company's net loss widened to 88.7 crore, as compared to 68.8 crore, year-on-year (Y-o-Y). Its revenue from operations stood at 290.3 crore, down 26 per cent Y-o-Y

OneSource Specialty Pharma Financials

OneSource Specialty Pharma Technicals

EMA & SMA

Current Price
₹1,715.40
-22.4 (-1.29%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹1,786.96
  • 50 Day
  • ₹1,705.87
  • 100 Day
  • ₹1,644.47
  • 200 Day
  • ₹1,636.95

Resistance and Support

1717.43 Pivot Speed
  • R3 1,762.77
  • R2 1,748.33
  • R1 1,731.87
  • S1 1,700.97
  • S2 1,686.53
  • S3 1,670.07

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

India’s first specialty pharma CDMO offers drug-device combinations, complex injectables, biologics, and soft gelatin capsules. Operating across multiple technology platforms, its 1,200+ professionals deliver tailored solutions for drug development and manufacturing with agility and expertise.

Onesource Specialty Pharma Ltd has an operating revenue of Rs. 1,421.59 Cr. on a trailing 12-month basis. An annual revenue de-growth of -2% needs improvement, Pre-tax margin of -6% needs improvement, ROE of -1% is poor and needs improvement. The company has a reasonable debt to equity of 10%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 3% and 4% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 11 which is a POOR score indicating inconsistency in earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 74 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

OneSource Specialty Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-13 Audited Results
2026-01-23 Quarterly Results
2025-11-11 Quarterly Results
2025-08-04 Quarterly Results
2025-05-05 Audited Results

OneSource Specialty Pharma Shareholding Pattern

30.48%
10.13%
3.35%
17.5%
0%
12.18%
26.36%

OneSource Specialty Pharma FAQs

OneSource Specialty Pharma share price is ₹1,715 As on 10 June, 2026 | 02:27

The Market Cap of OneSource Specialty Pharma is ₹19666.3 Cr As on 10 June, 2026 | 02:27

The P/E ratio of OneSource Specialty Pharma is -266.5 As on 10 June, 2026 | 02:27

The PB ratio of OneSource Specialty Pharma is 3.4 As on 10 June, 2026 | 02:27

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23